share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股sec公告 ·  08/07 09:56
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 08/07/2024, with an aggregate market value of approximately $1,086,990. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction. This planned sale follows a series of transactions over the past three months where Bozic sold a total of 11,400 shares, generating gross proceeds of over $5.4 million.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 08/07/2024, with an aggregate market value of approximately $1,086,990. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction. This planned sale follows a series of transactions over the past three months where Bozic sold a total of 11,400 shares, generating gross proceeds of over $5.4 million.
Vertex Pharmaceuticals Inc.官员Carmen Bozic打算于2024年08月07日卖出共2280股普通股,市值约为$1,086,990。这些股票于2024年02月24日作为限制性股票归属的一部分获得,是一项与补偿有关的交易。此次拟定的出售计划是在过去三个月中Bozic进行了一系列交易之后的行动,Bozic一共出售了11400股股票,获得了超过540万美元的收益。
Vertex Pharmaceuticals Inc.官员Carmen Bozic打算于2024年08月07日卖出共2280股普通股,市值约为$1,086,990。这些股票于2024年02月24日作为限制性股票归属的一部分获得,是一项与补偿有关的交易。此次拟定的出售计划是在过去三个月中Bozic进行了一系列交易之后的行动,Bozic一共出售了11400股股票,获得了超过540万美元的收益。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息